InvestorWire NewsRoom

InvestorNewsBreaks

Friday Jan 06, 2023 - 9:56 am

InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Study Results Indicating Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, is reporting additional results from a preclinical in vivo proof-of-concept study. The study evaluated BVXV’s innovative inhaled nanosized antibody (“NanoAb”) COVID-19 therapy; results indicate that the presence of the SARS-COV-2 virus in the lungs of hamsters treated with BiondVax’s NanoAb…

Continue Reading

Friday Jan 06, 2023 - 9:43 am

InvestorNewsBreaks – SideChannel Inc. (SDCH) CEO Weighs In on Cybersecurity Protection

SideChannel (OTCQB: SDCH) CEO Brian Haugli is one of several cybersecurity experts quoted in a recent “Information Week” article outlining five questions to ask about protecting a business. The article mentioned a widespread phishing campaign that took place last August against customer-engagement platform Twilio and content-delivery network Cloudflare. The cyberattack stole nearly 10,000 sets of credentials, with the tally rising much higher if downstream customers that…

Continue Reading

Thursday Jan 05, 2023 - 1:23 pm

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Starts Trading on Upstream

Nutriband (NASDAQ: NTRB), a pioneer in the science of using novel transdermal solutions and other innovative technologies, has announced that it has commenced trading on Upstream, a MERJ Exchange Market that is a fully regulated global stock exchange for digital securities and NFTs. The company, which began trading on Upstream today using the NTRB ticker symbol, is among the first issuers to dual list on…

Continue Reading

Thursday Jan 05, 2023 - 1:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Secures Stream of Steady Business on Fr8App Platform

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a company specializing in creating and providing supply chain optimization and automation solutions, and Freight App Inc. (“Fr8App”), its wholly owned subsidiary, have always sought to create offerings that contribute to their clients’ success by improving efficiency and profitability. “Designed to help solve shippers’ needs to secure freight capacity over time rather than on a trip-by-trip basis and guarantee carriers…

Continue Reading

Thursday Jan 05, 2023 - 1:02 pm

InvestorNewsBreaks – Marathon Digital Holdings Inc. (NASDAQ: MARA) Announces December 2022 BTC Production, Mining Operation Updates

Marathon Digital Holdings (NASDAQ: MARA), a leader in supporting and securing the bitcoin ecosystem, today released unaudited bitcoin (“BTC”) production and miner installation updates for December 2022. “In 2022, we made significant progress in increasing our hash rate while also transitioning to more sustainable power sources,” said Fred Thiel, Marathon’s chairman and CEO. “Despite challenges earlier in the year, we doubled our hash rate to…

Continue Reading

Thursday Jan 05, 2023 - 12:38 pm

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Receives Key Patent from European Patent Office

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, has been issued a patent by the European Patent Office. The company received notification that the patent was issued covering the company’s flagship technology that enables generation of a synthesized 12-lead ECG by the HeartBeam AIMIGo(TM) credit card-sized device. This patent…

Continue Reading

Thursday Jan 05, 2023 - 12:20 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at Virtual Investor 2023 ‘Companies to Watch’

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced that its Chief Executive Officer John Climaco will present at the Virtual Investor 2023 “Companies to Watch” event. Climaco’s presentation is scheduled to take place beginning at 10 a.m. ET on Wednesday, Jan. 18,…

Continue Reading

Thursday Jan 05, 2023 - 12:16 pm

InvestorNewsBreaks – MetAlert Inc. (MLRT) Issues Shareholder Update

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, today issued its year-end shareholder letter. In the update, the company’s CEO and Founder Patrick Bertagna shared insight on the company’s restructuring, branding and efforts to attract new investors and larger customers to execute its growth strategy, as well as the milestones that will shape MetAlert’s future.…

Continue Reading

Thursday Jan 05, 2023 - 11:41 am

InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Is Notified by NASDAQ Exchange of Full Compliance

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has regained full compliance with NASDAQ minimum-bid price requirements. The company received a letter from the NASDAQ Stock Market LLC providing notification of the change in status; the letter was dated Jan. 4, 2023. According to the letter, the exchange determined that the closing bid price of the company’s common stock was at or above $1…

Continue Reading

Thursday Jan 05, 2023 - 11:29 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Enters into Private Placement Agreement

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, has entered into a definitive agreement. According to the announcement, the agreement is with a single institutional investor and is estimated to raise $8 million through a private placement offering with a single unit…

Continue Reading

Thursday Jan 05, 2023 - 11:12 am

InvestorNewsBreaks – Splash Beverage Group Inc. (NYSE American: SBEV) Issues Corporate Update

Splash Beverage Group (NYSE American: SBEV), a portfolio company of leading beverage brands, today issued a letter to shareholders from Robert Nistico, SBEV’s CEO and chairman. “As we embark upon 2023, I wanted to take this opportunity to briefly update our shareholders on some key developments that have taken place at Splash Beverage Group since our last corporate update. Since our August update, we have…

Continue Reading

Thursday Jan 05, 2023 - 11:09 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Releases Status Update on Commercial Cannabis Export Business

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is reporting on its commercial cannabis operations out of Colombia. According to the status update, the company exported an estimated 1,000 kilograms of commercial cannabis dry flower and derivatives to Europe and the United States in the fourth quarter of 2022; the company also received an updated cannabis export…

Continue Reading

Thursday Jan 05, 2023 - 11:02 am

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Interim Results, Encouraging Trends for Phase II STOP Trial

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today announced interim results for the first five patients dosed in its Phase II STOP (Study of the Treatment of Overeating utilizing Psilocybin) trial. In collaboration with the University of Florida, the trial is evaluating TRP-8802 (oral psilocybin)…

Continue Reading

Thursday Jan 05, 2023 - 10:47 am

InvestorNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Announces Participation in Upcoming Biotech Showcase

BiondVax Pharmaceuticals (NASDAQ: BVXV) CEO Amir Reichman will be presenting at the Biotech Showcase Conference, scheduled for Jan. 9–11, 2023. The conference is being held in San Francisco during the J.P. Morgan 41st annual Healthcare Conference. BiondVax board chair Mark Germain will also be available throughout the conference to meet with potential partners, collaborators and investors. BiondVax is a biotech company focused on developing, manufacturing…

Continue Reading

Thursday Jan 05, 2023 - 10:34 am

InvestorNewsBreaks – SideChannel Inc. (SDCH) Featured on ‘Cyber for Hire’ Podcast

SideChannel (OTCQB: SDCH) was featured in a recent “Cyber for Hire – The Managed Security Podcast” published by SC Media. The piece delves into factors to consider when paring a company with a fractional or virtual CISO, looking at how to find a harmonious match. SideChannel’s founder and CEO Brian Haugli joined program co-hosts Bradley Barth and Ryan Morris to discuss the facets that go…

Continue Reading

Thursday Jan 05, 2023 - 10:27 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Inks Deal with University of Pittsburgh for Exclusive License to Diabetes Technology

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into an exclusive license agreement with the University of Pittsburgh. According to the announcement, the agreement gives Genprex a worldwide, exclusive license to a patent application along with related technology; the agreement also grants the company a worldwide, nonexclusive license to use certain related…

Continue Reading

Thursday Jan 05, 2023 - 10:01 am

InvestorNewsBreaks – Riot Platforms Inc. (NASDAQ: RIOT) Releases December 2022 Production, Operations Report

Riot Platforms (NASDAQ: RIOT), an industry leader in Bitcoin mining and data center hosting, is reporting unaudited production and operations numbers for December 2022. Highlights of the report note that Riot produced 659 BTC during the month, a 55% increase over the 425 BTC produced in December 2021. In addition, as of Dec. 31, 2022, the company held approximately 6,952 BTC, all produced by Riot’s…

Continue Reading

Wednesday Jan 04, 2023 - 1:44 pm

InvestorNewsBreaks – Universal Ibogaine Inc. (TSX.V: IBO) Recaps 2022, Eyes 2023 as ‘Pivotal Year’

Universal Ibogaine (TSX.V: IBO) (“UI”), a life sciences company with a mission to transform the addiction treatment industry with medicalized ibogaine-centered care, today provided a year-end summary of 2022 accomplishments. “2022 was a busy year of behind-the-scenes activity laying the foundations with Health Canada in preparation for the planned clinical trial application and sourcing the related ibogaine drug supply,” said Nick Karos, chief executive officer…

Continue Reading

Wednesday Jan 04, 2023 - 1:37 pm

InvestorNewsBreaks – Vision Energy Corp.’s (VENG) Pioneering Terminal Set to Accelerate Energy Transition

Vision Energy (OTCQB: VENG) recently entered into a corporation agreement with Linde Engineering to accelerate efforts for the company’s pioneering Green Energy Terminal in the North Sea Port of Vlissingen, the Netherlands. “Linde Engineering, a leading global industrial gases and engineering company with 2021 sales of $31 billion, will deliver preliminary Front-End Engineering and Design (‘FEED’) services to the project including design and engineering of…

Continue Reading

Wednesday Jan 04, 2023 - 1:17 pm

InvestorNewsBreaks – CubCrafters Inc.’s Distinctiveness in Backcountry Aviation Increases Demand for Its Aircraft

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has been modeled around a culture of innovation. This, coupled with the dedication and output of its now more than 200 highly skilled personnel, has propelled the company to be a leader in its market segment. “This status is evidenced by several parameters, including CubCrafters’ average aircraft revenue per customer,…

Continue Reading

Wednesday Jan 04, 2023 - 12:28 pm

InvestorNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Subsidiary Unveils Virtual Sensor for Auto Industry at CES 2023

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision, and its wholly owned subsidiary Eye-Net Mobile Ltd., have announced a new collision-prediction solution. Called Eye-Zone(TM), the solution is a virtual sensor designed for the automotive industry. Eye-Zone will be on display at CES 2023, which will be held in Las Vegas on Jan. 5–8, 2023. CES visitors will be able to meet…

Continue Reading

Wednesday Jan 04, 2023 - 12:16 pm

InvestorNewsBreaks – IBN Launches Customized Investor Relations Solution

IBN, a multifaceted financial news and publishing company for private and public entities, today announced the launch of Investor Relations Plus (+), its customized IR solution designed to support both issuers and IR professionals. IBN continually works to adapt to the evolving needs of its client partners, and with offerings such as press release enhancement through InvestorWire, gleans insight from traditional PR professionals and IR…

Continue Reading

Wednesday Jan 04, 2023 - 11:58 am

InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Biotech Showcase

Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients with unmet medical need conditions, today announced that its CEO Dr. David Young will present an update on Processa’s future therapeutic focus and strategy at the upcoming Biotech Showcase. The presentation is scheduled to begin at 10 a.m. PT on Jan. 11, 2023. Interested parties…

Continue Reading

Wednesday Jan 04, 2023 - 11:42 am

InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA Clearance of Proprietary Oral Appliance for Obstructive Sleep Apnea Treatment

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (“OSA”) and snoring in adults, has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for its own daytime-nighttime appliance (“DNA”). According to the announcement, the clearance for the DNA appliance as a Class II device “gives rise…

Continue Reading

Wednesday Jan 04, 2023 - 11:26 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Gene Therapy Treatment Data to be Presented at Upcoming International Diabetes Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that research evaluating the company’s gene therapy for type 1 diabetes will be presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (“ATTD”). The preclinical data will be presented by GNPX research collaborators at the University of Pittsburg. The conference will…

Continue Reading

Wednesday Jan 04, 2023 - 10:58 am

InvestorNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Announces Review on Molecular Basis of Dupuytren’s Disease

180 Life Sciences (NASDAQ: ATNF) today announced the publication of a review entitled “Dupuytren’s disease: a localized and accessible human fibrotic disorder” in the journal Trends in Molecular Medicine. In the article, the authors at the University of Oxford, led by Professor Jagdeep Nanchahal, chairman of the medical advisory board of 180 Life Sciences, describe the biology of Dupuytren’s disease, to which their important contributions…

Continue Reading

Wednesday Jan 04, 2023 - 10:42 am

InvestorNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Set to Begin IGC-AD1 Phase 2 Trials at Sites Throughout Canada

India Globalization Capital (NYSE American: IGC) today announced its receipt of a no objection letter from Health Canada for approval of its “Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial of the Safety and Efficacy of IGC-AD1 on Agitation in Participants with Dementia due to Alzheimer’s Disease.” The letter provides the acknowledgement of IGC-AD1’s drug candidacy and the authority to proceed with phase 2 trials in…

Continue Reading

Wednesday Jan 04, 2023 - 10:26 am

InvestorNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Integration of IPT Carbonation Process into Crawford Project

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company focused on advancing the next generation of nickel-sulphide projects, today announced that its latest test work results support the incorporation of carbon capture and storage into the Crawford Project. According to the update, Canada Nickel’s In-Process Tailings (“IPT”) Carbonation process is a novel method for accelerated carbon capture and storage that the company believes has transformative potential.…

Continue Reading

Wednesday Jan 04, 2023 - 10:02 am

InvestorNewsBreaks – SideChannel Inc. (SDCH) CEO Shares Purposeful Approach to Security Strategy in Hacker Valley Podcast

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent podcast produced by Hacker Valley Studio. The discussion centers around strategy and leadership in cybersecurity, with Haugli sharing what he has learned about a purposeful approach. “Strategy is not technology, it’s figuring out what you want to look like when you grow up, in a sense,” Haugli said, discussing his philosophy and…

Continue Reading

Tuesday Jan 03, 2023 - 2:33 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Strategic Board Appointment of Faith L. Charles, JD

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced its appointment of Faith L. Charles as chair of its board of directors. Since 2010, Charles has served as a corporate transactions and securities partner at the law firm of Thompson Hine, LLP. She currently leads the…

Continue Reading

Tuesday Jan 03, 2023 - 1:28 pm

InvestorNewsBreaks — Stronghold Digital Mining Inc. (NASDAQ: SDIG) to Extinguish Convertible Notes Through Exchange Agreement

Stronghold Digital Mining (NASDAQ: SDIG), a vertically integrated Bitcoin mining company with an emphasis on environmentally beneficial operations, has entered into an exchange agreement with the holders of the company’s amended and restated 10% notes. According to the announcement, the result is that the approximately $17.9 million of outstanding principal amount of debt and interest will be extinguished in exchange for shares of a new…

Continue Reading

Tuesday Jan 03, 2023 - 1:24 pm

InvestorNewsBreaks – Riot Platforms Inc. (NASDAQ: RIOT) Announces Rebranding to Reflect Its Corporate Vision

Riot Platforms (NASDAQ: RIOT) (formerly Riot Blockchain Inc.), an industry leader in Bitcoin mining and data center hosting, today announced the rebranding of its corporate name from Riot Blockchain Inc. to Riot Platforms Inc. The move underpins the company’s growth strategy to continue expanding its increasingly diversified business operations and reflects a renewal of its corporate vision to become the world’s leading Bitcoin-driven infrastructure platform.…

Continue Reading

Tuesday Jan 03, 2023 - 1:14 pm

InvestorNewsBreaks – SPYR Inc. (SPYR) Reports on CEO Year-End Comments

SPYR (OTCQB: SPYR) CEO Tim Matula has released comments regarding the company, which is a diversified technology company developing products leveraging the Internet of Things (IoT) for consumer use and large-scale applications and industries. Matula commented on noteworthy events during 2022 as well as the company’s outlook for 2023. After thanking shareholders, Matula noted that 2022 was “eventful” for SPRY, including the introduction of new management…

Continue Reading

Tuesday Jan 03, 2023 - 1:06 pm

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Forms Subsidiary with Focus on Immune Modulation Therapies

Aditxt (NASDAQ: ADTX) is a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system. The company today announced the formation of a U.S.-based subsidiary Adimune Inc. (“Adimune(TM)”) and its plans towards submission of a clinical trial application (“CTA”) for its immunotherapeutic technology drug candidate, ADI(TM)-100. The CTA application will request approval for Adimune to conduct the first-in-human…

Continue Reading

Tuesday Jan 03, 2023 - 1:01 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Unveils New Lidar That Embodies Auto Industry’s Biggest Trends, Next-Gen Innovations

Cepton (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, today announced the unveiling of its groundbreaking new lidar, the Vista(R)-X120 Plus. The world’s slimmest software definable, top-end automotive lidar for real-time adaptive 3D perception, the Vista-X120 Plus embodies the automotive industry’s biggest trends – safety, autonomy, software definability and electrification – and packs Cepton’s next-generation innovations. “The Vista-X120 Plus’ upgraded scanning mechanism enables…

Continue Reading

Tuesday Jan 03, 2023 - 12:33 pm

InvestorNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) to Demonstrate Unique Technological Advances at CES 2023

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it will showcase a live demonstration of its Mono2Stereo(TM) software-based solution at CES 2023. According to the update, the solution is designed to create 3D perception stereo vision from existing cameras to enhance the performance of existing mono-camera based advanced driver assistance systems (“ADAS”). “The year 2022 saw significant…

Continue Reading

Tuesday Jan 03, 2023 - 12:21 pm

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Validates Position as Leading Provider of Integrated Solutions in Employer and Payer Markets

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a large Northeast U.S. supermarket chain selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023. This marks 100 enterprise contracts signed for DarioHealth and validates its strategic position as a leading provider of integrated digital chronic condition management solutions in the…

Continue Reading

Tuesday Jan 03, 2023 - 12:14 pm

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), MGH to Collaborate in Clinical Study Investigating Psilocybin-Assisted Psychotherapy for IBS Patients

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs. The company today announced its entry into a letter of intent with Massachusetts General Hospital (“MGH”), the largest teaching hospital of Harvard Medical School, to fund and conduct a phase 2a clinical trial investigating the effects of…

Continue Reading

Tuesday Jan 03, 2023 - 12:10 pm

InvestorNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) to Present at 25th Annual Needham Growth Conference

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, today announced its participation in the 25th annual Needham Growth Conference. The event is slated to take place from Jan. 10 - 12, 2023, at The Lotte New York Palace in New York City. The company is scheduled to present at 4:30 p.m. ET on Jan. 10, and…

Continue Reading

Tuesday Jan 03, 2023 - 12:06 pm

InvestorNewsBreaks – SideChannel Inc. (SDCH) CEO Featured on NBC News

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent video interview published by NBC News. The piece discusses an alert issued by the FBI and Homeland Security over cyber attacks targeting the data of teachers, staff and even students as schools come back in session. NBC News’ Tom Winter speaks with stakeholders and experts in the fight against cyber crime as…

Continue Reading

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).